Autolus Therapeutics

NASDAQ: AUTL · Real-Time Price · USD
1.34
-0.07 (-4.96%)
At close: May 01, 2025, 3:59 PM
1.36
1.12%
After-hours: May 01, 2025, 07:50 PM EDT

Autolus Therapeutics Revenue

Autolus Therapeutics reported an annual revenue of $10.12M, reflecting a undefined% growth. For the quarter ending December 31, 2024, Autolus Therapeutics generated $29K in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
357.94M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 10.12M +496.00%
Dec 31, 2023 1.7M -72.59%
Dec 31, 2022 6.19M +165.84%
Dec 31, 2021 2.33M +862.81%
Dec 31, 2020 242K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.